Pneumococcal Vaccination Offers Dual Benefit for Heart and Lung Health, Pfizer Reports (PHOTO)
Cologne, Germany - A pneumococcal vaccination can simultaneously bolster both cardiac and pulmonary health, according to new information released by Pfizer Pharma GmbH. the vaccine provides protection against pneumococcal disease, a leading cause of serious infections, and emerging research suggests a link between pneumococcal pneumonia and increased risk of cardiovascular events.
This dual protection is notably crucial as individuals age or manage underlying health conditions. Pneumococcal disease can lead to pneumonia, bloodstream infections, and meningitis, placing notable strain on the body – including the cardiovascular system. By preventing these infections, the vaccination may reduce the risk of associated heart complications, offering a proactive approach to overall wellbeing.
Anna Meier-Rink of IPG-PR, can be reached at jmeier-rink@ipg-pr.com or +49 (0) 170 - 5443244 for further information. Additional details are available at www.presseportal.de.
(PHOTO: enjoy life with a strong heart and healthy lungs thanks to the pneumococcal vaccination. © Pfizer Pharma GmbH)
